Ceftriaxone and Tazobactam Injection

PRODUCT NAME : Ceforf-TZ

Dosage Form: Injection

Packing: Vial

Ceftriaxone & Tazobactam Injection is a broad-spectrum antibacterial formulation designed to treat a wide range of bacterial infections. This combination brings together Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor that enhances the effectiveness of the antibiotic by protecting it from bacterial enzyme degradation.

This injection is commonly prescribed for the treatment of respiratory tract infections, urinary tract infections (UTIs), skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and other serious bacterial infections caused by susceptible microorganisms. The combination provides improved antibacterial coverage against resistant bacteria, making it a preferred choice for healthcare professionals in clinical practice.

Manufactured under strict quality standards, Ceftriaxone & Tazobactam Injection offers reliable efficacy, consistent quality, and excellent safety when administered under medical supervision. It is intended for intravenous (IV) or intramuscular (IM) use as directed by a qualified healthcare provider.

At Biomorph Lifesciences, we are committed to delivering high-quality pharmaceutical formulations that meet international manufacturing standards. Our Ceftriaxone & Tazobactam Injection is produced in WHO-GMP compliant facilities, ensuring quality, purity, and patient safety. It is an ideal choice for hospitals, clinics, and pharmaceutical distributors seeking trusted and effective antibacterial solutions.

Category: Injection

Description

Description

MORE DETAILS ABOUT PRODUCT

Ceforf-Tz 562.5mg

Ceftriaxone is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, providing rapid and effective bactericidal activity against susceptible bacteria.
Tazobactam is a beta-lactamase inhibitor that protects Ceftriaxone from degradation by beta-lactamase enzymes produced by resistant bacteria, enhancing its antibacterial efficacy.
Offers broad-spectrum antibacterial coverage against a wide range of Gram-positive and Gram-negative bacteria, including many beta-lactamase-producing strains.
Commonly prescribed for the treatment of respiratory tract infections, urinary tract infections (UTIs), intra-abdominal infections, skin and soft tissue infections, bone and joint infections, septicemia, gynecological infections, and other susceptible bacterial infections.

Indications

Key Benefits of Ceforf-TZ 562.50

Broad-spectrum antibacterial coverage against Gram-positive and Gram-negative bacteria.
Combines Ceftriaxone and Tazobactam for enhanced antibacterial effectiveness.
Helps combat beta-lactamase-producing resistant bacterial strains.
Provides bactericidal action by inhibiting bacterial cell wall synthesis.
Clinically proven formulation for the treatment of severe bacterial infections.
Suitable for intravenous (IV) and intramuscular (IM) administration.
Effective in treating respiratory, urinary tract, and intra-abdominal infections.
Delivers consistent therapeutic results with a trusted antibiotic combination.